www.fda.gov
Open in
urlscan Pro
2a02:26f0:fb:593::2e60
Public Scan
Submitted URL: http://www.fda.gov/novelcoronavirus
Effective URL: https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-20...
Submission: On February 10 via api from US — Scanned from DE
Effective URL: https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-20...
Submission: On February 10 via api from US — Scanned from DE
Form analysis
2 forms found in the DOMName: searchForm — GET https://search.usa.gov/search
<form class="fda-masthead__search sr-only" role="search" action="https://search.usa.gov/search" method="GET" name="searchForm" id="search-form" accept-charset="UTF-8">
<div class="search-popover" id="search-popover">
<div class="input-group pull-right" id="search-group">
<label class="sr-only" for="search-query">Search FDA</label>
<input accesskey="4" class="form-control search-input" id="search-query" name="query" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA" type="text">
<span class="input-group-btn" id="input-group-btn">
<button type="submit" class="btn btn-danger search-btn" id="search-btn" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button>
</span>
</div>
</div>
<input name="affiliate" value="fda1" type="hidden">
</form>
POST https://public.govdelivery.com/accounts/USFDA/subscribers/qualify
<form class="form-horizontal" id="GD-snippet-form" action="https://public.govdelivery.com/accounts/USFDA/subscribers/qualify" accept-charset="UTF-8" method="post">
<input name="utf8" type="hidden" value="✓">
<input type="hidden" name="authenticity_token" value="VJuyc1HyD63+xVCkN+K9qiH1bD9zSSJ+BfdR1d4LXjZ0BncrJ/u9dEw/e0U869OeCw6JxhyYXfnZCCGNF1oVkQ==">
<input type="hidden" name="topic_id" id="topic_id" value="USFDA_135">
<label class="sr-only" for="email">Enter your email address to subscribe:</label>
<div class="input-group subscribe-group">
<input type="email" name="email" id="email" placeholder="Email Address" class="form-control">
<span class="input-group-btn"><input class="btn btn-primary" type="submit" name="commit" value="Subscribe"></span>
</div>
</form>
Text Content
* Skip to main content * Skip to FDA Search * Skip to in this section menu * Skip to footer links An official website of the United States government Here’s how you know The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. U.S. FOOD AND DRUG ADMINISTRATION * Search * Menu Search FDA Submit search FEATURED * Contact FDA * FDA Guidance Documents * Recalls, Market Withdrawals and Safety Alerts * Press Announcements * Warning Letters * Advisory Committees * En Español PRODUCTS * Food * Drugs * Medical Devices * Radiation-Emitting Products * Vaccines, Blood, and Biologics * Animal and Veterinary * Cosmetics * Tobacco Products TOPICS * About FDA * Combination Products * Regulatory Information * Safety * Emergency Preparedness * International Programs * News and Events * Training and Continuing Education * Inspections and Compliance * Science and Research INFORMATION FOR * Consumers * Patients * Industry * Health Professionals * Federal, State and Local Officials In this section: Counterterrorism and Emerging Threats * Coronavirus Disease 2019 (COVID-19) * COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders * COVID-19 Frequently Asked Questions * COVID-19 Vaccines * Innovation to Respond to COVID-19 * COVID-19 Educational Resources * COVID-19 Communication Toolkits * Multilingual COVID-19 Resources 1. Home 2. Emergency Preparedness and Response 3. Counterterrorism and Emerging Threats 4. Coronavirus Disease 2019 (COVID-19) 1. Counterterrorism and Emerging Threats CORONAVIRUS DISEASE 2019 (COVID-19) Subscribe to Email Updates * Share * Tweet * Linkedin * Email * Print Español COVID-19 VACCINE BOOSTER INFORMATION AND ELIGIBILITY ON THIS PAGE: * Latest COVID-19 News from FDA * Personal Protective Equipment * Emergency Use Authorizations and Guidances * Frequently Asked Questions * Popular Topics * FDA Response to COVID-19 * COVID-19 Information About FDA Regulated Products * Contact FDA * Information from the Federal Government COVID-19 VACCINES * Pfizer-BioNTech COVID-19 Vaccine & Comirnaty * Moderna COVID-19 Vaccine & Spikevax * Janssen COVID-19 Vaccine COVID-19 FAQS Frequently asked questions (FAQs) in English and Spanish. RESOURCES FOR HEALTH PROFESSIONALS Key resources for health professionals during the COVID-19 pandemic. LATEST COVID-19 INFORMATION FROM THE FDA Type of Information COVID-19 UpdateDaily RoundupPress Release / Public StatementEventFDA Voices: Leadership PerspectivesSafety InformationConsumer InformationPodcast / Video Topic Animal & VeterinaryBiologicsDrugsFood & BeveragesGuidance DocumentsImportsInspectionsMedical DevicesRecallsResearchTobacco ProductsWarning Letters Clear Filters Search: Show 102550100All entries Export Excel Date Update Type Topic 02/08/2022 FDA Roundup: February 8, 2022 The FDA issued a guidance for industry and investigators to announce a policy discouraging sponsors from developing or seeking approval or authorization for the use of sanitation tunnels, that spray humans with a mist of disinfectant or aerosolized antiseptic with the aim of preventing or treating COVID-19. The agency also warned health care providers, parents and caregivers of pediatric patients (children) who receive enteral feeding that there is a risk of strangulation from the use of enteral feeding delivery sets. Press Release / Public Statement Drugs Medical Devices 02/04/2022 FDA Roundup: February 4, 2022 The FDA determined that beginning on Feb. 7, the agency will resume conducting domestic surveillance inspections across all commodities given the decline in COVID-19 cases across the country. The FDA also issued a draft guidance advising sponsors on the premarketing assessment of a drug’s effect on blood pressure. Additionally, the FDA announced its 2022-2025 strategic priorities for the Center for Devices and Radiological Health, a proposed rule to improve the security of the drug supply chain as well as a new website showcasing the Center for Veterinary Medicine’s innovative research to protect human and animal health. Press Release / Public Statement Drugs Animal & Veterinary Medical Devices 02/01/2022 Coronavirus (COVID-19) Update: FDA Advisory Committee Meeting to Discuss Request for Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age FDA announced a virtual meeting of its Vaccines and Related Biological Products Advisory Committee on Feb. 15 to discuss the request for emergency use authorization of the Pfizer-BioNTech COVID-19 Vaccine for use in children 6 months through 4 years of age. Press Release / Public Statement Biologics Showing 1 to 3 of 613 entries * Previous * 1 * 2 * 3 * 4 * 5 * … * 205 * Next PERSONAL PROTECTIVE EQUIPMENT Conservation strategies for PPE and other resources. * N95 respirators, surgical masks, and face masks * Medical gloves * Medical gowns * Medical glove conservation strategies * Surgical mask and gown conservation strategies EMERGENCY USE AUTHORIZATIONS AND GUIDANCES EMERGENCY USE AUTHORIZATIONS (EUAS) Expedited authorization of medical products to address public health emergencies. GUIDANCE DOCUMENTS AND POLICIES Policies and guidances to support rapid response to COVID-19. FREQUENTLY ASKED QUESTIONS (FAQS) ENGLISH Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions ESPAÑOL Preguntas frecuentes sobre la Enfermedad del Coronavirus 2019 (COVID-19) MORE FAQS ON SPECIFIC TOPICS * Hand sanitizer FAQs * FAQs on testing for SARS-CoV-2 * 3D printing of medical devices & parts FAQs * Medical glove FAQs * Surgical mask & gown shortage FAQs * Face mask & surgical mask FAQs * Food industry FAQs * Ventilator FAQs * Animal food safety & COVID-19 industry FAQs * Manufacturing, supply chain, & drug inspections FAQs POPULAR CORONAVIRUS TOPICS COVID-19 TESTING COVID-19 TREATMENTS COVID-19 VACCINES INFORMATION FOR PEOPLE WITH HEALTH CONDITIONS FRAUDULENT PRODUCTS FOOD SAFETY INNOVATION REMDESIVIR HAND SANITIZER SAFETY FDA RESPONSE TO COVID-19 How FDA facilitates development and availability of medical countermeasures to combat COVID-19 with Medical Devices (PDF) and Therapeutics (PDF) FDA 2021 YEAR IN REVIEW - WORKING FOR YOU (PDF) CDER RESPONSE TO CORONAVIRUS (COVID-19): INFOGRAPHIC FDA COVID-19 PANDEMIC RECOVERY AND PREPAREDNESS PLAN (PREPP) INITIATIVE CDRH RESPONSE TO COVID-19 IN 2020 FDA RESPONSE: INFOGRAPHIC (PDF) CORONAVIRUS TREATMENT ACCELERATION PROGRAM (CTAP) COVID-19 INFORMATION ABOUT FDA REGULATED PRODUCTS Learn more about how FDA is facilitating the development and availability of medical countermeasures and protecting the public health. FOOD DRUGS MEDICAL DEVICES ANIMAL & VETERINARY BIOLOGICS CONTACT FDA DIAGNOSTIC TEST DEVELOPERS See FAQs on Diagnostic Testing for SARS-CoV-2. If you need additional information about completing the EUA template, would like to know how to submit your Pre-EUA/EUA submission to FDA, or wish to consider use of an alternative specimen type, please contact the Division of Microbiology Devices at (301) 348-1778 or email CDRH-EUA-Templates@fda.hhs.gov. VACCINE & BIOLOGIC DEVELOPERS Contact Manufacturers Assistance and Technical Training Branch (MATTB). Email industry.biologics@fda.hhs.gov or call 1-800-835-4709 for further information. DRUG DEVELOPERS For therapeutics sponsors interested in submitting drug development proposals for review, see COVID-19 Therapeutics: General Information for Interested Stakeholders. Email covid19-productdevelopment@fda.hhs.gov PHYSICIANS SEEKING AN EMERGENCY IND Please call 855-543-3784 if you are a physician who would like to request an Emergency Investigational New Drug (EIND) application for antiviral products PRESS / MEDIA FDA’s Office of Media Affairs * Email fdaoma@fda.hhs.gov * Call 301-796-4540 ALL OTHER INQUIRIES FDA’s main Contact Us page REPORT A PROBLEM * Fraudulent Products (1-800-332-1088) * Shortages or Supply Issues * Import Problem INFORMATION FROM THE FEDERAL GOVERNMENT CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) How to prepare and protect yourself, what to do if you’re sick, vaccines – and more… VACCINES.GOV Find a COVID-19 vaccine near you, get the latest COVID-19 vaccine information, and connect with the COVID-19 Vaccine Hotline COVID-19 TREATMENT GUIDELINES Evidence-based recommendations on the management of COVID-19 for health care providers USA.GOV/CORONAVIRUS The federal government response to COVID-19, including stimulus payments OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION Information for workers and employers about COVID-19 from the U.S. Department of Labor FEDERAL EMERGENCY MANAGEMENT AGENCY (FEMA) How FEMA is supporting COVID-19 vaccine distribution, COVID-19 rumor control, and how you can help during the pandemic CONTENT CURRENT AS OF: 02/08/2022 * TOPIC(S) * Emergencies HEALTH TOPIC(S) * Infectious Disease * Coronavirus * Coronavirus Disease 2019 (COVID-19) * COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders * COVID-19 Frequently Asked Questions * COVID-19 Vaccines * Innovation to Respond to COVID-19 * COVID-19 Educational Resources * COVID-19 Communication Toolkits * Multilingual COVID-19 Resources SUBSCRIBE Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures, COVID-19, and other emerging infectious diseases. Enter your email address to subscribe: FOOTER LINKS * FDA Archive * About FDA * Accessibility * Visitor Information * Website Policies / Privacy * No FEAR Act * FOIA * HHS.gov * USA.gov Contact FDA Follow FDA on Facebook Follow FDA on Twitter View FDA videos on YouTube Subscribe to FDA RSS feeds FDA Homepage Contact Number 1-888-INFO-FDA (1-888-463-6332) Back to Top